Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Symbol
PLRX
Shares outstanding
61,059,490 shares
Disclosed Ownership
2,991,915 shares
Ownership
4.9%
Form type
SCHEDULE 13G
Filing time
22 Jan 2026, 19:02:44 UTC
Date of event
14 Jan 2026
Next filing
30 Jan 2026

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 4.9% ownership in PLIANT THERAPEUTICS, INC. Common stock, par value $0.0001 per share (the "Shares") (PLRX) on 14 Jan 2026."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G for PLIANT THERAPEUTICS, INC. Common stock, par value $0.0001 per share (the "Shares") (PLRX).
  • Disclosed ownership: 4.9%.
  • Date of event: 14 Jan 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 22 Jan 2026, 19:02.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 3.4% 2,099,798 0 2,099,798 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 3.4% 2,099,798 0 2,099,798 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 3.4% 2,099,798 0 2,099,798 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 1.4% 863,391 0 863,391 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 1.5% 892,117 0 892,117 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 1.5% 892,117 0 892,117 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 4.9% 2,991,915 0 2,991,915 /s/ Seth Levy Seth Levy, attorney-in-fact*